Consistent with these findings, our results showed that SMIM25 expression was significantly upregulated in HCC tissues compared to adjacent non-cancerous tissues, and was also associated with poor prognosis in HCC patients. This evidence concerns the gene PELATON and hepatocellular carcinoma.